Press "Enter" to skip to content

New patent expiration for Gilead drug LETAIRIS

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead drug LETAIRIS

Annual Drug Patent Expirations for LETAIRIS
Annual Drug Patent Expirations for LETAIRIS

Letairis is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for LETAIRIS.

This drug has one hundred and three patent family members in thirty-five countries.

The generic ingredient in LETAIRIS is ambrisentan. One supplier is listed for this compound. Additional details are available on the ambrisentan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead drug LETAIRIS
Do NOT follow this link or you will be banned from the site!